BDBM50334482 4-((3-(3,5-dichlorophenyl)-5-(4-(trifluoromethoxy)phenyl)-1H-pyrazol-1-yl)methyl)-N-(2H-tetrazol-5-yl)benzamide::CHEMBL1644184

SMILES FC(F)(F)Oc1ccc(cc1)-c1cc(nn1Cc1ccc(cc1)C(=O)Nc1nnn[nH]1)-c1cc(Cl)cc(Cl)c1

InChI Key InChIKey=IQBYLOOYQGIZCS-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50334482   

TargetGlucagon receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50334482(4-((3-(3,5-dichlorophenyl)-5-(4-(trifluoromethoxy)...)
Affinity DataIC50:  330nMAssay Description:Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucagon receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50334482(4-((3-(3,5-dichlorophenyl)-5-(4-(trifluoromethoxy)...)
Affinity DataIC50:  39nMAssay Description:Displacement of [125I]glucagon from human GCGR expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50334482(4-((3-(3,5-dichlorophenyl)-5-(4-(trifluoromethoxy)...)
Affinity DataIC50:  7.10E+3nMAssay Description:Antagonist activity at human GIPR expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed